GUERINI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 551
EU - Europa 327
AS - Asia 237
SA - Sud America 2
AF - Africa 1
Totale 1.118
Nazione #
US - Stati Uniti d'America 547
SG - Singapore 84
IT - Italia 82
PL - Polonia 66
DE - Germania 48
CN - Cina 41
HK - Hong Kong 39
FI - Finlandia 33
TR - Turchia 25
RU - Federazione Russa 21
VN - Vietnam 20
GB - Regno Unito 19
UA - Ucraina 17
IE - Irlanda 16
ID - Indonesia 14
CZ - Repubblica Ceca 11
IN - India 5
SE - Svezia 3
AT - Austria 2
AZ - Azerbaigian 2
CA - Canada 2
FR - Francia 2
NL - Olanda 2
AR - Argentina 1
BG - Bulgaria 1
BY - Bielorussia 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
MX - Messico 1
PK - Pakistan 1
SL - Sierra Leone 1
UZ - Uzbekistan 1
Totale 1.118
Città #
Singapore 74
Ashburn 69
Warsaw 66
Chandler 58
New York 57
Fairfield 52
Hong Kong 38
Helsinki 30
Princeton 24
Boardman 22
Istanbul 22
Seattle 22
Shanghai 21
Dong Ket 20
Cambridge 16
Dublin 16
Jacksonville 16
Brescia 14
Houston 14
Jakarta 14
Wilmington 14
Woodbridge 13
Munich 12
Los Angeles 11
Moscow 10
Brno 8
Ann Arbor 7
London 7
Rome 6
Beijing 5
Romola 5
San Diego 5
Milan 4
Pune 4
Washington 4
Cremona 3
Baku 2
Berlin 2
Bologna 2
Chiswick 2
Dalmine 2
Dearborn 2
Des Moines 2
Fort Worth 2
Guangzhou 2
Lappeenranta 2
Prague 2
Roseville 2
San Francisco 2
Siena 2
Toronto 2
Vienna 2
Amman 1
Bishkek 1
Buenos Aires 1
Central 1
Changsha 1
Chicago 1
Cittadella 1
Colombo 1
Dallas 1
Delaware 1
Espoo 1
Falkenstein 1
Freetown 1
Groningen 1
Guayaquil 1
Gunzenhausen 1
Hanover 1
Hebei 1
Hefei 1
Hounslow 1
Islamabad 1
Jieyang 1
Jinan 1
Kilburn 1
Kocaeli 1
Latina 1
Leawood 1
Mexico City 1
Miami Beach 1
Minsk 1
Napa 1
Nave 1
Ningbo 1
Nuvolento 1
Pontirolo Nuovo 1
Prineville 1
Redwood City 1
San Mateo 1
Seoul 1
Sofia 1
Southwark 1
Stockholm 1
Taranto 1
Tashkent 1
Tianjin 1
Turin 1
Vientiane 1
Wandsworth 1
Totale 863
Nome #
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 126
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 102
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 92
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 87
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 76
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 64
Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum 54
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 49
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 48
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 47
Stratification of Oligometastatic Prostate Cancer Patients by Liquid Biopsy: Clinical Insights from a Pilot Study 46
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients 44
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy 44
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 40
Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy 31
The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy 26
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques 21
The role of feature-based radiomics for predicting response and radiation injury after stereotactic radiation therapy for brain metastases: A critical review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO) 20
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia 19
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 19
Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the 'radio talk' webinars 19
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 18
Prognostic role of baseline 18 F‐FDG pet/CT in squamous cell carcinoma of the paranasal sinuses 17
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 16
null 13
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 10
Totale 1.148
Categoria #
all - tutte 10.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.248


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202043 0 0 0 0 0 0 9 8 7 10 4 5
2020/2021241 8 5 28 22 20 17 22 18 21 34 15 31
2021/2022104 6 17 6 5 2 5 2 8 5 9 2 37
2022/2023172 19 7 8 7 19 37 3 17 25 4 19 7
2023/2024360 10 8 41 13 16 89 19 23 43 18 12 68
2024/2025218 6 17 16 86 35 58 0 0 0 0 0 0
Totale 1.148